NCT00111436View on ClinicalTrials.gov

Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects

PHASE3CompletedINTERVENTIONAL

Enrollment

912

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions

Psoriasis

Interventions

DRUG

Etanercept

Enbrel 50 mg once weekly or 50 mg twice weekly

Sponsors

Lead Sponsor

Collaborators (1)

Immunex Corporation

All Listed Sponsors

collaborator

Immunex Corporation

INDUSTRY

collaborator

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

Amgen

INDUSTRY